Cancer Research UK logo.
SearchDonate
  • Search

A study of ofatumumab with CHOP chemotherapy for Richter's syndrome (CHOP-OR)

Overview

Cancer types:

Blood cancers, Cell type, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), High grade lymphoma, Leukaemia, Lymphoma, Non-Hodgkin lymphoma (NHL)

Status:

Results

Phase:

Phase 2

Details

Chronic lymphocytic leukaemia (CLL) can sometimes develop into a condition called Richter’s syndrome. Richter’s syndrome is a type of lymphoma.

Cancer Research UK supported this study.

Recruitment start: 27 April 2011

Recruitment end: 16 December 2014

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Anna Schuh

Supported by

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

GlaxoSmithKline (GSK)

NIHR Clinical Research Network: Cancer

University of Oxford

Other information

This is Cancer Research UK trial number CRUKE/09/038.

Last reviewed: 29 May 2017

CRUK internal database number: 4460

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.